Insulin Resistance Is Not a Disease: A Metabolic Reframe

Key Takeaways

• 90% of US adults are prediabetic or diabetic.
• Chronic glucose oversupply drives insulin resistance as protective response.
• Current care focuses on insulin and meds, not dietary cause.
• Reducing refined carbohydrate intake addresses root cause of CEBS.
• Medical education privileges pharmacology over metabolic nutrition interventions.

Summary

Type 2 diabetes is reframed as chronic elevated blood sugar (CEBS) rather than a disease of insulin deficiency. The article argues that what is labeled "insulin resistance" is a protective cellular response to persistent glucose oversupply caused by excessive carbohydrate consumption. It criticizes the medical system’s reliance on insulin and glucose‑lowering drugs while neglecting dietary root causes. The piece calls for shifting focus to nutrition and metabolic education to prevent downstream chronic illnesses.

Pulse Analysis

The United States now faces a metabolic tipping point: roughly nine in ten adults are prediabetic or diabetic, a statistic that reflects a systemic excess of circulating glucose rather than a failure of insulin production. By redefining type 2 diabetes as chronic elevated blood sugar (CEBS), the narrative shifts from a mysterious disease to a predictable physiological state driven by continuous carbohydrate overload. This reframing highlights insulin’s true role as a messenger that signals nutrient availability, while the so‑called "insulin resistance" emerges as a protective throttling mechanism against intracellular stress.

Despite this insight, the healthcare infrastructure remains anchored in a pharmaceutical paradigm. Medical curricula prioritize drug mechanisms, reimbursement models reward medication prescriptions, and clinical guidelines emphasize insulin titration over dietary modification. Consequently, clinicians often manage the symptom—high blood sugar—without confronting the upstream cause: relentless intake of refined carbs and sugars. This structural bias not only inflates treatment costs but also sidelines preventive nutrition strategies that could curb the progression to fatty liver disease, cardiovascular complications, and neurodegeneration.

Redirecting focus toward upstream interventions could transform public health outcomes. Policies that incentivize nutrition counseling, reform insurance coverage to include metabolic education, and support research on low‑carbohydrate dietary protocols would empower both providers and patients. By addressing the root cause—excessive glucose exposure—health systems can reduce reliance on lifelong medication, lower chronic disease burden, and restore coherence to metabolic care. The shift from symptom suppression to cause elimination promises a more sustainable, cost‑effective approach to tackling the diabetes epidemic.